Acetylsalicylic acid Recruiting Phase 1 Trials for Head and Neck Carcinoma Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Recruiting | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03245489 | Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |